Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9876 - 9900 of 12697 in total
AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways implicated in cancer cell proliferation and survival. AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including melanoma, pancreatic, colon, lung, and breast cancers.
Investigational
Matched Description: … AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including …
AZD1305 has been used in trials studying the treatment and basic science of Atrial Flutter, Atrial Fibrillation, and Left Ventricle Function.
Investigational
Matched Description: … AZD1305 has been used in trials studying the treatment and basic science of Atrial Flutter, Atrial Fibrillation …
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
Investigational
Matched Description: … Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal …
Experimental
Experimental
Experimental
BMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies.
Investigational
Matched Description: … BMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing …
Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.
Investigational
Matched Description: … Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast …
Experimental
Displaying drugs 9876 - 9900 of 12697 in total